Osivax SAS is a company that provides Universal flu vaccine, Medicine, Clinical trial and more. Osivax SAS is headquartered in France . Osivax SAS was founded in 2017. Osivax SAS has a total of 32 patents
visualizing technology portfolio of hot application areas and blank areas for Osivax SAS
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for Osivax SAS
Sign up to view the full data
Free Trial Now
Download
Osivax SAS Frequently Asked Questions
What technical fields has Osivax SAS researched?
Osivax SAS has researched the technical fields related toUniversal flu vaccineMedicineClinical trialSafety syringeAutoinjectorInfluenza preventionSewing needleInjectorSyringeDrug developmentDrug discoveryImmunotherapyBiotechnology
Osivax is a developer of immunotherapy vaccines intended to facilitate the treatment of infectious diseases. The company's vaccines expedite the uptake...
What is Osivax SAS's official website?
Osivax SAS's official website is http://www.osivax.com.